MEG3 has been reported to regulate miR-21, target Caspase-8 to regulate proliferation and apoptosis of psoriatic epidermal cells, and inactivate the PI3K/Akt pathway to promote apoptosis in breast cancer cells (Jia et al., 2019; Zhu et al., 2019). Here, MEG3 is linked to breast cancer.